Skip to main content

ORIGINAL RESEARCH article

Front. Nucl. Med.

Sec. Radiopharmacy and Radiochemistry

Volume 5 - 2025 | doi: 10.3389/fnume.2025.1585027

Comparison of Carbonic Anhydrase-IX-targeted Trifunctional Radioligands between Linear-and Branched-chain Arrangements

Provisionally accepted
  • Kyoto University, Kyoto, Japan

The final, formatted version of the article will be published soon.

    Background: Carbonic anhydrase-IX (CA-IX) is overexpressed in tumors due to hypoxic conditions and considered an attractive biomarker for tumor-targeting radioligands. The introduction of an albumin binder (ALB) to radioligands can delay their renal clearance, resulting in increased radioactivity delivered to tumors and decreased renal uptake of radioligands. In this study, we designed novel CA-IX-targeted trifunctional radioligands consisting of imidazothiadiazole sulfonamide (IS) as a CA-IX-targeted ligand, DOTA as a chelator with four free carboxylic groups, and lysine-conjugated 4-(p-iodophenyl)butyric acid (Lys-IPBA) as ALB, with IS-[111In]In-DOTADG-ALB in a linear-chain arrangement and [111In]In-DOTAGA-ALB-IS in a branched-chain arrangement. Fundamental properties of IS-[111In]In-DOTADG-ALB and [111In]In-DOTAGA-ALB-IS were evaluated by in vitro and in vivo assays.Methods: IS-DOTADG-ALB and DOTAGA-ALB-IS were synthesized and radiolabeled with [111In]InCl3. The stability of IS-[111In]In-DOTADG-ALB and [111In]In-DOTAGA-ALB-IS was evaluated by HPLC analysis after incubation in murine plasma. A cell saturation binding assay using CA-IX-positive HT-29 cells and albumin-binding assay were performed for IS-[111In]In-DOTADG-ALB and [111In]In-DOTAGA-ALB-IS to evaluate their capacity to bind CA-IX and albumin. Biodistribution assays of IS-[111In]In-DOTADG-ALB and [111In]In-DOTAGA-ALB-IS were performed using HT-29 tumor-bearing mice to evaluate their pharmacokinetics.Results: IS-[111In]In-DOTADG-ALB and [111In]In-DOTAGA-ALB-IS were successfully synthesized by ligand substitution reaction from their corresponding precursors. IS-[111In]In-DOTADG-ALB and [111In]In-DOTAGA-ALB-IS exhibited similar stabilities in murine plasma and affinities to CA-IX, although the affinities to albumin were higher for [111In]In-DOTAGA-ALB-IS compared with IS-[111In]In-DOTADG-ALB. In the biodistribution assays, [111In]In-DOTAGA-ALB-IS showed higher blood retention and tumor accumulation and lower renal uptake than IS-[111In]In-DOTADG-ALB, reflecting their albumin-binding affinities.Conclusion: These data suggest that the branched-chain arrangement of DOTAGA-ALB-IS may be useful for the design of CA-IX-targeted radioligands consisting of an IS ligand, DOTA, and Lys-IPBA.

    Keywords: CA-IX, Imidazothiadiazole sulfonamide, DOTA, albumin binder, linear-chain arrangement, branched-chain arrangement

    Received: 28 Feb 2025; Accepted: 31 Mar 2025.

    Copyright: © 2025 Nakashima, Ichinose, Watanabe and Ono. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Masahiro Ono, Kyoto University, Kyoto, Japan

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

    Research integrity at Frontiers

    Man ultramarathon runner in the mountains he trains at sunset

    95% of researchers rate our articles as excellent or good

    Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


    Find out more